Islam KU, Iqbal J. An update on molecular diagnostics for COVID-19. Front Cell Infect Microbiol. 2020;10:560616.

PubMed  PubMed Central  Google Scholar 

Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: virology, biology and novel laboratory diagnosis. J Gene Med. 2021;23:e3303.

CAS  PubMed  PubMed Central  Google Scholar 

Chen TH, Hsu MT, Lee MY, Chou CK. Gastrointestinal involvement in SARS-CoV-2 infection. Viruses. 2022;14.

Hossain B, Malik F, Khan A, Abidi M, Marhaba A, Oranu A, et al. Prevalence and impact of Gastrointestinal manifestations in COVID-19 patients: A systematic review. J Community Hosp Intern Med Perspect. 2023;13:39–54.

PubMed  PubMed Central  Google Scholar 

Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:143.

CAS  PubMed  PubMed Central  Google Scholar 

Ashraf UM, Abokor AA, Edwards JM, Waigi EW, Royfman RS, Hasan SA, et al. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics. 2021;53:51–60.

CAS  PubMed  Google Scholar 

Bortolotti D, Simioni C, Neri LM, Rizzo R, Semprini CM, Occhionorelli S, et al. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage. FASEB J. 2021;35:e21969.

CAS  PubMed  Google Scholar 

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11.

CAS  PubMed  PubMed Central  Google Scholar 

Rizzo R, Neri LM, Simioni C, Bortolotti D, Occhionorelli S, Zauli G, et al. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient. Clin Microbiol Infect. 2021;27:936–7.

CAS  PubMed  PubMed Central  Google Scholar 

Zamboni P, Bortolotti D, Occhionorelli S, Traina L, Neri LM, Rizzo R, et al. Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab. J Intern Med. 2022;291:224–31.

CAS  PubMed  Google Scholar 

Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526:135–40.

CAS  PubMed  PubMed Central  Google Scholar 

Zamboni P. COVID-19 as a vascular disease: lesson learned from imaging and blood biomarkers. Diagnostics (Basel). 2020;10:440.

Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial damage in acute respiratory distress syndrome. Int J Mol Sci. 2020;21.

Smadja DM, Philippe A, Bory O, Gendron N, Beauvais A, Gruest M, et al. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021;19:1823–30.

CAS  PubMed  Google Scholar 

Zeng FM, Li YW, Deng ZH, He JZ, Li W, Wang L, et al. SARS-CoV-2 Spike Spurs intestinal inflammation via VEGF production in enterocytes. EMBO Mol Med. 2022;14:e14844.

CAS  PubMed  PubMed Central  Google Scholar 

Sundararaman A, Mellor H. A functional antagonism between RhoJ and Cdc42 regulates fibronectin remodelling during angiogenesis. Small GTPases. 2021;12:241–5.

CAS  PubMed  Google Scholar 

Sarpdag F, Yonem O, Aktas A, Seckin Y, Tuncer E, Ozer H. Colonic fibronectin and E-cadherin in mild ulcerative colitis. Bratisl Lek Listy. 2021;122:331–5.

CAS  PubMed  Google Scholar 

Eyileten C, Wicik Z, Simoes SN, Martins-Jr DC, Klos K, Wlodarczyk W, et al. Thrombosis-related Circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. RNA Biol. 2022;19:963–79.

CAS  PubMed  PubMed Central  Google Scholar 

Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, et al. Large-Scale Multi-omic analysis of COVID-19 severity. Cell Syst. 2021;12:23–40. e7.

CAS  PubMed  Google Scholar 

Lemanska-Perek A, Krzyzanowska-Golab D, Dragan B, Tyszko M, Adamik B. Fibronectin as a marker of disease severity in critically ill COVID-19 patients. Cells. 2022;11.

Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J Virol. 2023;12:68–90.

PubMed  PubMed Central  Google Scholar 

Simioni C, Sanz JM, Gafa R, Tagliatti V, Greco P, Passaro A, Neri LM. Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues. J Mol Histol. 2024;55:753–764.

Karakasis P, Nasoufidou A, Sagris M, Fragakis N, Tsioufis K. Vascular alterations following COVID-19 infection: A comprehensive literature review. Life (Basel). 2024;14:545.

Miesbach W, Makris M. COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost. 2020;26:1076029620938149.

CAS  PubMed  PubMed Central  Google Scholar 

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089–98.

CAS  PubMed  PubMed Central  Google Scholar 

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834–47.

CAS  PubMed  PubMed Central  Google Scholar 

Maldonado F, Morales D, Diaz-Papapietro C, Valdes C, Fernandez C, Valls N, et al. Relationship between endothelial and angiogenesis biomarkers envisage mortality in a prospective cohort of COVID-19 patients requiring respiratory support. Front Med (Lausanne). 2022;9:826218.

PubMed  Google Scholar 

Meini S, Giani T, Tascini C. Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2. Mol Biol Rep. 2020;47:8301–4.

CAS  PubMed  PubMed Central  Google Scholar 

Lin H, Cao B. Circulating VEGF and inflammatory bowel disease: a bidirectional Mendelian randomization. Front Genet. 2024;15:1282471.

CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Wang S, Xue A, Shi J, Zheng C, Huang Y. Thalidomide inhibits angiogenesis via downregulation of VEGF and Angiopoietin-2 in Crohn’s disease. Inflammation. 2021;44:795–807.

CAS  PubMed  Google Scholar 

Mateescu RB, Bastian AE, Nichita L, Marinescu M, Rouhani F, Voiosu AM, et al. Vascular endothelial growth factor - key mediator of angiogenesis and promising therapeutical target in ulcerative colitis. Rom J Morphol Embryol. 2017;58:1339–45.

PubMed  Google Scholar 

Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, et al. Inflammatory and Microbiota-Related regulation of the intestinal epithelial barrier. Front Nutr. 2021;8:718356.

PubMed  PubMed Central  Google Scholar 

Assimakopoulos SF, Eleftheriotis G, Lagadinou M, Karamouzos V, Dousdampanis P, Siakallis G, Marangos M. SARS CoV-2-Induced viral sepsis: the role of gut barrier dysfunction. Microorganisms. 2022;10:1050.

Citi S. Intestinal barriers protect against disease. Science. 2018;359:1097–8.

CAS  PubMed  Google Scholar 

Eleftheriotis G, Tsounis EP, Aggeletopoulou I, Dousdampanis P, Triantos C, Mouzaki A, et al. Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential. Front Immunol. 2023;14:1129190.

CAS  PubMed  PubMed Central  Google Scholar 

Luo Y, Zhang Z, Ren J, Dou C, Wen J, Yang Y, et al. SARS-Cov-2 Spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9. Front Immunol. 2024;15:1303356.

CAS  PubMed  PubMed Central  Google Scholar 

Yamada S, Noda T, Okabe K, Yanagida S, Nishida M, Kanda Y. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium. J Pharmacol Sci. 2022;149:139–46.

CAS  PubMed  PubMed Central  Google Scholar 

Greco S, Sanz JM, Bortolotti D, Semprini CM, Braga C, Gafa R, et al. Case report: tissue positivity for SARS-CoV-2 in a preterm born infant death of thrombosis: possible intrauterine transmission. Front Med (Lausanne). 2023;10:1127529.

PubMed  Google Scholar 

Zuo W, He D, Liang C, Du S, Hua Z, Nie Q, et al. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect Dis. 2024;24:845–55.

CAS  PubMed  Google Scholar